(Q34791678)

4 August 2017

Modulation of striatal dopamine release by 5-HT2A and 5-HT2C receptor antagonists: [11C]raclopride PET studies in the rat. (English)

1 reference

4 August 2017

0 references

1 reference

Alice Egerton

1

1 reference

4 August 2017

Rabia Ahmad

series ordinal

2

1 reference

4 August 2017

Ella Hirani

series ordinal

3

1 reference

4 August 2017

Paul M Grasby

series ordinal

4

1 reference

4 August 2017

3 July 2008

1 reference

4 August 2017

1 reference

4 August 2017

200

1 reference

4 August 2017

4

1 reference

4 August 2017

487-496

1 reference

https://scigraph.springernature.com/pub.10.1007/s00213-008-1226-4

4 August 2017

0 references

cites work

Relationship between dopaminergic and serotonergic neuronal activity in the frontal cortex and the action of typical and atypical antipsychotic drugs

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-008-1226-4

Serotonin-dopamine interaction and its relevance to schizophrenia

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-008-1226-4

In vitro and in vivo profile of SB 206553, a potent 5-HT2C/5-HT2B receptor antagonist with anxiolytic-like properties

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-008-1226-4

The potential of high-resolution positron emission tomography to monitor striatal dopaminergic function in rat models of disease

21 January 2018

1 reference

12 December 2020

SB 242084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system

1 reference

12 December 2020

Measurement of methylphenidate-induced change in extrastriatal dopamine concentration using [11C]FLB 457 PET.

1 reference

12 December 2020

Constitutive activity of the serotonin2C receptor inhibits in vivo dopamine release in the rat striatum and nucleus accumbens.

1 reference

12 December 2020

Role of striatal serotonin2A and serotonin2C receptor subtypes in the control of in vivo dopamine outflow in the rat striatum

1 reference

12 December 2020

Inverse agonist and neutral antagonist actions of antidepressants at recombinant and native 5-hydroxytryptamine2C receptors: differential modulation of cell surface expression and signal transduction

1 reference

12 December 2020

Distribution of serotonin 5-HT2C receptors in the ventral tegmental area

1 reference

12 December 2020

5-HT2A and 5-HT2C/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum.

1 reference

12 December 2020

Fenfluramine evokes 5-HT2A receptor-mediated responses but does not displace [11C]MDL 100907: small animal PET and gene expression studies

1 reference

12 December 2020

Binding of typical and atypical antipsychotic agents to transiently expressed 5-HT1C receptors

1 reference

12 December 2020

Serotonin-dopamine interaction in the rat ventral tegmental area: an electrophysiological study in vivo

1 reference

12 December 2020

Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission

1 reference

12 December 2020

Pattern of expression of the serotonin2C receptor messenger RNA in the basal ganglia of adult rats

1 reference

12 December 2020

Novel actions of inverse agonists on 5-HT2C receptor systems.

1 reference

12 December 2020

Role of serotonin 2A receptors in the D-amphetamine-induced release of dopamine: comparison with previous data on alpha1b-adrenergic receptors

1 reference

12 December 2020

Role of serotonin(2A) and serotonin(2B/2C) receptor subtypes in the control of accumbal and striatal dopamine release elicited in vivo by dorsal raphe nucleus electrical stimulation.

1 reference

12 December 2020

5-Methyl-1-(3-pyridylcarbamoyl)-1,2,3,5-tetrahydropyrrolo[2,3-f]indole: a novel 5-HT2C/5-HT2B receptor antagonist with improved affinity, selectivity, and oral activity

1 reference

12 December 2020

5-HT2A and alpha1b-adrenergic receptors entirely mediate dopamine release, locomotor response and behavioural sensitization to opiates and psychostimulants

1 reference

12 December 2020

Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin(2C/2B) receptor agonists: a combined in vivo electrophysiological and microdialysis study

1 reference

12 December 2020

5-HT2 receptors differentially modulate dopamine-mediated auto-inhibition in A9 and A10 midbrain areas of the rat.

1 reference

12 December 2020

Pharmacological constraints associated with positron emission tomographic scanning of small laboratory animals.

1 reference

12 December 2020

Placebo-controlled evaluation of four novel compounds for the treatment of schizophrenia and schizoaffective disorder

1 reference

12 December 2020

Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes

1 reference

12 December 2020

Serotonin receptors: their key role in drugs to treat schizophrenia

1 reference

12 December 2020

GBR12909 attenuates amphetamine-induced striatal dopamine release as measured by [(11)C]raclopride continuous infusion PET scans.

1 reference

12 December 2020

Is synaptic dopamine concentration the exclusive factor which alters the in vivo binding of [11C]raclopride?: PET studies combined with microdialysis in conscious monkeys

1 reference

12 December 2020

An open label trial of raclopride in acute schizophrenia. Confirmation of D2-dopamine receptor occupancy by PET

1 reference

12 December 2020

Fluvoxamine treatment and D2 receptors: a pet study on OCD drug-naïve patients.

1 reference

12 December 2020

DOI, a 5-HT2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat striatum

1 reference

12 December 2020

Evidence for expression of the 5-hydroxytryptamine-2B receptor protein in the rat central nervous system

1 reference

12 December 2020

Modulation of dopamine release by striatal 5-HT2C receptors

1 reference

12 December 2020

5-HT2A receptor stimulation by DOI, a 5-HT2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens

1 reference

12 December 2020

Uncoupling between noradrenergic and serotonergic neurons as a molecular basis of stable changes in behavior induced by repeated drugs of abuse

1 reference

12 December 2020

5-hydroxytryptamine2A receptor inverse agonists as antipsychotics

1 reference

12 December 2020

Serotonergic modulation of striatal dopamine measured with positron emission tomography (PET) and in vivo microdialysis

1 reference

12 December 2020

Ketanserin and spiperone as templates for novel serotonin 5-HT(2A) antagonists

1 reference

12 December 2020

Regulation of striatal dopamine release through 5-HT1 and 5-HT2 receptors.

1 reference

12 December 2020

Physiological relevance of constitutive activity of 5-HT2A and 5-HT2C receptors

1 reference

12 December 2020

m-Chlorophenylpiperazine excites non-dopaminergic neurons in the rat substantia nigra and ventral tegmental area by activating serotonin-2C receptors

1 reference

12 December 2020

Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review

1 reference

12 December 2020

1 reference

12 December 2020

5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man--a PET study with [11C]raclopride.

1 reference

12 December 2020

A software system for interactive and quantitative visualization of multidimensional biomedical images

1 reference

12 December 2020

Characterization of the 5-HT2 receptor antagonist MDL 100907 as a putative atypical antipsychotic: behavioral, electrophysiological and neurochemical studies.

1 reference

12 December 2020

Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat

1 reference

12 December 2020

Serotonin (5-HT)2A receptor activation enhances dialysate levels of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely-moving rats

1 reference

12 December 2020

Effect of 5-HT on binding of [(11)C] WAY 100635 to 5-HT(IA) receptors in rat brain, assessed using in vivo microdialysis nd PET after fenfluramine

1 reference

12 December 2020

Inverse agonist activity of atypical antipsychotic drugs at human 5-hydroxytryptamine2C receptors

1 reference

12 December 2020

Regional effects of MK-801 on dopamine release: effects of competitive NMDA or 5-HT2A receptor blockade.

1 reference

12 December 2020

Ketanserin pretreatment attenuates MDMA-induced dopamine release in the striatum as measured by in vivo microdialysis

1 reference

12 December 2020

Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values

1 reference

12 December 2020

Characterization of radioactive metabolites of 5-HT2A receptor PET ligand [18F]altanserin in human and rodent

1 reference

12 December 2020

Biochemical and pharmacological properties of SR 46349B, a new potent and selective 5-hydroxytryptamine2 receptor antagonist.

1 reference

12 December 2020

Balance between dopamine and serotonin release modulates behavioral effects of amphetamine-type drugs

1 reference

12 December 2020

Tyrosine-free amino acid mixture attenuates amphetamine-induced displacement of [11C]raclopride in striatum in vivo: a rat PET study

1 reference

12 December 2020

5-HT2 receptors exert a state-dependent regulation of dopaminergic function: studies with MDL 100,907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine

1 reference

12 December 2020

Region-dependent regulation of mesoaccumbens dopamine neurons in vivo by the constitutive activity of central serotonin2C receptors

1 reference

12 December 2020

Selective blockade of serotonin-2C/2B receptors enhances mesolimbic and mesostriatal dopaminergic function: a combined in vivo electrophysiological and microdialysis study

1 reference

12 December 2020

Temporal characterisation of amphetamine-induced dopamine release assessed with [11C]raclopride in anaesthetised rodents

1 reference

12 December 2020

Selective blockade of serotonin2C/2B receptors enhances dopamine release in the rat nucleus accumbens.

1 reference

12 December 2020

10.1007/S00213-008-1226-4

Identifiers

DOI

1 reference

Dimensions Publication ID

4 August 2017

0 references

1 reference